In 2023, Medikaloka Hermina completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Medikaloka Hermina has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2023, the total operational greenhouse gas (GHG) emissions of Medikaloka Hermina amounted to 35,236,049.789 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Medikaloka Hermina increased by 2.26%, suggesting that the company faced challenges in reducing its emissions from its core operations.
In 2023, the total Scope 1 emissions of Medikaloka Hermina were 0.803 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Since 2020, Medikaloka Hermina's Scope 1 emissions have decreased by 25.37%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Medikaloka Hermina's Scope 1 emissions decreased by 72.47%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
In 2023, Medikaloka Hermina reported Scope 2 greenhouse gas (GHG) emissions of 35,236,048.986 tCOâ‚‚e without specifying the calculation method.
Since 2020, Medikaloka Hermina's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 88.66%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Medikaloka Hermina's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Medikaloka Hermina 's emissions have plateaued with no significant change in its energy consumption footprint.
In 2023, Medikaloka Hermina reported its Scope 2 emissions using an unspecified methodology.